Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning? | Clin J Am Soc Nephrol;18(4): 427-429, 2023 04 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety of Nirmatrelvir/Ritonavir in Dialysis Patients with COVID-19: The End of the Beginning?

Yilmam, Osman A; Leaf, David E.

Yilmam OA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Clin J Am Soc Nephrol ; 18(4): 427-429, 2023 04 01.

Article in English | MEDLINE | ID: covidwho-2306156

Subject(s)

COVID-19; Ritonavir; Humans; Ritonavir/adverse effects; Renal Dialysis; COVID-19 Drug Treatment; Antiviral Agents/adverse effects

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ritonavir / COVID-19 Limits: Humans Language: English Journal: Clin J Am Soc Nephrol Journal subject: Nephrology Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ritonavir / COVID-19 Limits: Humans Language: English Journal: Clin J Am Soc Nephrol Journal subject: Nephrology Year: 2023 Document Type: Article